PTSD Comorbidity Articles Article Review by scribbler
PTSD Comorbidity Articles
Reviews two articles about post traumatic stress disorder (PTSD) comorbidity.
# 152792
| 1,595 words
| 4 sources
| APA
| 2013
|

Published
on Apr 29, 2013
in
Psychology
(Disorders)
, Medical and Health
(Pharmacy)
, Research Designs
(General)
$19.95
Buy and instantly download this paper now
Description:
This paper summarizes, relates the strengths and weaknesses and suggests the clinical relevance of two journal articles reporting studies about the comorbidity of post traumatic stress disorder (PTSD). The first article by J. Spinazzola et al, "Posttraumatic Stress Disorder Treatment Outcome Research: the Study of Unrepresentative Samples?", the author asserts, argues that the comorbidity between PTSD and certain conditions, which are viewed as excluding factors for the isolation of the PTSD condition, is sufficiently high thus this exclusion needs to be reconsidered. The second article by B, Van der Kolk et al, "A Randomized Clinical Trial of Eye ... in the Treatment of Posttraumatic Stress Disorder", the paper reports, concludes that, because PTSD is traced frequently to specific events and therefore to specific cognitive processing disorders, the most optimal treat of PTSD may not be drug course strategies.
Table of Contents:
Article 1
Summary
Strengths
Weaknesses
Clinical Relevance
Article 2
Summary
Strengths
Weaknesses
Clinical Relevance
Table of Contents:
Article 1
Summary
Strengths
Weaknesses
Clinical Relevance
Article 2
Summary
Strengths
Weaknesses
Clinical Relevance
From the Paper:
"The study in question would include 88 participants, all of whom had been previously diagnosed with PTSD and related symptoms denoting a stress-related disorder. The study would use the DSM-IV-approved Clinician Administered PTSD Scale and the Beck Depression Inventory-II in order to measure subjects both before and after treatment intervention. Subsequently, individuals were divided into pharmacological and therapeutic treatment groups. The former were given a selective serotonin reuptake inhibitor (SSRI) called fluoxetine while the latter will given a placebo and engaged in an eye movement desensitization reprocessing (EMDR) therapy."The major impetus for the research is quite a compelling one. According to van der Kolk et al (2007), "comparing the relative effectiveness of pharmacotherapy versus exposure therapy is particularly relevant in the treatment of PTSD, since the SSRIs are widely used to treat PTSD, particularly in primary care and health maintenance organization (HMO) settings, where little attention may be paid to helping patients 'process' their traumas." The research ultimately supports this assumption, revealing that roughly 75% of adult-onset participants receiving therapeutic treatment would show 'end-state functioning' according to the aforementioned measurement tools. This would compare to a stunning 0% achievement of end-state functioning for those just receiving the SSRI."
Sample of Sources Used:
- Ross, C. A. (2007). The trauma model. Richardson, TX: Manitou Communications, Inc.
- Spinazzola, J.; Blaustein, M. & van der Kolk, B. (2005). Posttraumatic Stress Disorder Treatment Outcome Research: the Study of Unrepresentative Samples? Journal of Traumatic Stress, 18(5), 425-436.
- Van der Kolk, B.; Spinazzola, J.; Blausteiin, M.E.; Hopper, J.W.; Hopper, E.K.; Korn, D.L. & Simpson, W.B. (2007). A Randomized Clinical Trial of Eye Movement Desensitization and Reprocessing (EMDR), Fluoxetine, and Pill Placebo in the Treatment of Posttraumatic Stress Disorder: Treatment Effects and Long-Term Maintenance. Journal of Clinical Psychiatry, 68.
- Wilson, J.P., Friedman, M.J. & Linday, J.D (2004). Treating psychological trauma & PTSD. New York, NY Guilford Press.
Cite this Article Review:
APA Format
PTSD Comorbidity Articles (2013, April 29)
Retrieved June 07, 2023, from https://www.academon.com/article-review/ptsd-comorbidity-articles-152792/
MLA Format
"PTSD Comorbidity Articles" 29 April 2013.
Web. 07 June. 2023. <https://www.academon.com/article-review/ptsd-comorbidity-articles-152792/>